South Korea Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

South Korea Blood Glucose Monitoring Market is Segmented Into Type (Self-Monitoring Blood Glucose and Continuous Glucose Monitoring), Component (Glucometer Devices, Test Strips, Lancets, Sensors, And Durables). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

South Korea Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

South Korea Blood Glucose Monitoring Market Size

View Global Report
South Korea Blood Glucose Monitoring Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 247.38 Million
Market Size (2030) USD 365.16 Million
CAGR (2025 - 2030) 8.10 %

Major Players

South Korea Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of South Korea Blood Glucose Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

South Korea Blood Glucose Monitoring Market Analysis

The South Korea Blood Glucose Monitoring Market size is estimated at USD 247.38 million in 2025, and is expected to reach USD 365.16 million by 2030, at a CAGR of 8.1% during the forecast period (2025-2030).

The blood glucose device market in South Korea has experienced significant growth in recent years, largely driven by the increasing population of individuals with diabetes. Similar to other developed countries, South Korea has witnessed a rise in diabetes prevalence due to factors such as an aging population, urbanization, and changes in lifestyle habits including dietary patterns and reduced physical activity.

With the rising number of diabetes diagnoses in South Korea, there is a growing demand for blood glucose monitoring devices to aid patients in effectively managing their condition. These devices play a crucial role in diabetes management by allowing individuals to regularly monitor their blood sugar levels and make informed decisions regarding their diet, exercise, and medication adjustments.

The South Korean blood glucose device market offers a wide range of products, including traditional blood glucose meters, continuous glucose monitoring (CGM) systems, and flash glucose monitoring systems. Traditional blood glucose meters remain popular among many patients due to their affordability and ease of use. However, there has been an increasing interest in CGM systems, which provide continuous, real-time glucose monitoring without the need for frequent fingerstick tests.

The growing adoption of blood glucose monitoring devices in South Korea signifies a shift towards personalized and proactive approaches to diabetes management. These devices not only assist individuals with diabetes in maintaining better control of their blood sugar levels but also empower them to make lifestyle changes that can reduce the risk of diabetes-related complications in the long run.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

South Korea Blood Glucose Monitoring Industry Overview

The blood glucose monitoring market is highly fragmented, with few major manufacturers present in the market. The CGM devices market is dominated by major players like Dexcom, Medtronics, Abbott, and Senseonics. The market for BGM devices comprises more generic players like Roche, LifeScan, Arkray, Ascensia, etc. Technological innovations in the recent past helped companies to strengthen their market presence.

South Korea Blood Glucose Monitoring Market Leaders

  1. Roche

  2. Abbott

  3. Medtronics

  4. Dexcom

  5. LifeScan

  6. *Disclaimer: Major Players sorted in no particular order
South Korea Blood Glucose Monitoring Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

South Korea Blood Glucose Monitoring Market News

  • July 2023: i-SENS, a CGM manufacturer based in South Korea, announced that it has obtained regulatory clearance for CareSens Air, the initial CGM device developed domestically. In March, i-SENS submitted the required documentation to the government for approval. The Ministry of Food and Drug Safety did not require additional supporting paperwork, resulting in an earlier approval than expected.
  • August 2021: FIND announced that agreements had been signed with i-SENS, Inc. (Seoul, South Korea) and SD BIOSENSOR, Inc. (Suwon-si, South Korea) to increase low- and middle-income countries (LMIC) access to blood glucose test strips by improving affordability.

South Korea Blood Glucose Monitoring Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Self-monitoring blood glucose devices
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets
  • 5.2 Continuous blood glucose monitoring devices
    • 5.2.1 Sensors
    • 5.2.2 Durables (Receivers and Transmitters)

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Holding AG
    • 7.1.3 LifeScan
    • 7.1.4 Dexcom Inc.
    • 7.1.5 Medtronic PLC
    • 7.1.6 Arkray Inc.
    • 7.1.7 Ascensia Diabetes Care
    • 7.1.8 Agamatrix Inc.
    • 7.1.9 Bionime Corporation
    • 7.1.10 Acon Laboratories Inc.
    • 7.1.11 Trivida Functional Medicine
    • 7.1.12 Senseonics
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 Roche Holding AG
    • 7.2.1.3 LifeScan
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom Inc.
    • 7.2.2.2 Medtronic PLC
    • 7.2.2.3 Abbott Diabetes Care

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

South Korea Blood Glucose Monitoring Industry Segmentation

Continuous glucose monitoring (CGM) systems, another type of blood glucose monitoring device, provide real-time glucose readings throughout the day via a sensor inserted under the skin, transmitting data wirelessly to a receiver or smartphone app. These devices play a crucial role in helping individuals with diabetes make informed decisions about their diet, medication, and lifestyle to maintain optimal blood sugar control and prevent complications associated with the disease. South Korea Blood Glucose Monitoring Market is segmented into type and component. The report offers the value (in USD) and volume (in Units) for the above segments.

Self-monitoring blood glucose devices Glucometer Devices
Test Strips
Lancets
Continuous blood glucose monitoring devices Sensors
Durables (Receivers and Transmitters)
Need A Different Region or Segment?
Customize Now

South Korea Blood Glucose Monitoring Market Research FAQs

How big is the South Korea Blood Glucose Monitoring Market?

The South Korea Blood Glucose Monitoring Market size is expected to reach USD 247.38 million in 2025 and grow at a CAGR of 8.10% to reach USD 365.16 million by 2030.

What is the current South Korea Blood Glucose Monitoring Market size?

In 2025, the South Korea Blood Glucose Monitoring Market size is expected to reach USD 247.38 million.

Who are the key players in South Korea Blood Glucose Monitoring Market?

Roche, Abbott, Medtronics, Dexcom and LifeScan are the major companies operating in the South Korea Blood Glucose Monitoring Market.

What years does this South Korea Blood Glucose Monitoring Market cover, and what was the market size in 2024?

In 2024, the South Korea Blood Glucose Monitoring Market size was estimated at USD 227.34 million. The report covers the South Korea Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the South Korea Blood Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

South Korea Blood Glucose Monitoring Industry Report

Statistics for the 2025 South Korea Blood Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. South Korea Blood Glucose Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.